In Vivo and In Vitro Models to Study Amyotrophic Lateral Sclerosis

kod QR

In Vivo and In Vitro Models to Study Amyotrophic Lateral Sclerosis

None

Zapisane w:

Opis bibliograficzny
Główni autorzy:	Berthod, François, Gros-Louis, François
Format:	Elektroniczne Rozdział
Język:	angielski
Wydane:	IntechOpen 2012
Hasła przedmiotowe:	Life Sciences
Dostęp online:	https://www.intechopen.com/chapters/26530
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Genetics of Amyotrophic Lateral Sclerosis
od: Koppers, Max, i wsp.
Wydane: (2012)

Genetics of Familial Amyotrophic Lateral Sclerosis
od: Goodall, Emily F., i wsp.
Wydane: (2012)

Multidisciplinary Rehabilitation in Amyotrophic Lateral Sclerosis
od: Ng, Louisa, i wsp.
Wydane: (2012)

Amyotrophic Lateral Sclerosis: An Introduction to Treatment and Trials
od: Maurer, Martin H.
Wydane: (2012)

Molecular and Electrical Abnormalities in the Mouse Model of Amyotrophic Lateral Sclerosis
od: Quinlan, Katharina A., i wsp.
Wydane: (2012)

Protein Aggregates in Pathological Inclusions of Amyotrophic Lateral Sclerosis
od: Furukawa, Yoshiaki
Wydane: (2012)

Human Computer Interactions for Amyotrophic Lateral Sclerosis Patients
od: Uşaklı, Ali Bülent
Wydane: (2012)

Assessment and Management of Respiratory Dysfunction in Patients with Amyotrophic Lateral Sclerosis
od: Coco, Daniele Lo, i wsp.
Wydane: (2012)

Insights Arising from Gene Expression Profiling in Amyotrophic Lateral Sclerosis
od: Cooper-Knock, Johnathan, i wsp.
Wydane: (2012)

Nutritional Care in Amyotrophic Lateral Sclerosis: An Alternative for the Maximization of the Nutritional State
od: Carvalho-Silva, Luciano Bruno de
Wydane: (2012)

Electrophysiological Abnormalities in SOD1 Transgenic Models in Amyotrophic Lateral Sclerosis: The Commonalities and Differences
od: Elbasiouny, Sherif M., i wsp.
Wydane: (2012)

Dynamic Meta-Analysis as a Therapeutic Prediction Tool for Amyotrophic Lateral Sclerosis
od: Mitchell, Cassie S., i wsp.
Wydane: (2012)

Epidemiology of amyotrophic lateral sclerosis in the Krasnoyarsk region
od: E. A. Ermilov, i wsp.
Wydane: (2024-01-01)

Mutant Cu/Zn-Superoxide Dismutase Induced Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
od: Koistinaho, Jari, i wsp.
Wydane: (2012)

Stem Cell Application for Amyotrophic Lateral Sclerosis: Growth Factor Delivery and Cell Therapy
od: Suzuki, Masatoshi, i wsp.
Wydane: (2012)

How to Assess Disease’s Severity and Monitor Patients with Amyotrophic Lateral Sclerosis: Lessons from Neurophysiology
od: Sartucci, Ferdinando, i wsp.
Wydane: (2012)

Oxidative Modifications of Cu, Zn-Superoxide Dismutase (SOD1) – The Relevance to Amyotrophic Lateral Sclerosis (ALS)
od: Nagano, Seiichi
Wydane: (2012)

Sleep disorders of insomnia type in patients with amyotrophic lateral sclerosis
od: G. N. Levitskiy, i wsp.
Wydane: (2017-11-01)

Genetics of familial amyotrophic lateral sclerosis
od: A. V. Savinova, i wsp.
Wydane: (2021-10-01)

Management of Dysarthria in Amyotrophic Lateral Sclerosis
od: Elena Pasqualucci, i wsp.
Wydane: (2025-07-01)

Deontological aspects of the amyotrophic lateral sclerosis
od: T. M. Alekseeva, i wsp.
Wydane: (2018-01-01)

Palliative health care for amyotrophic lateral sclerosis patients
od: M. N. Zakharova, i wsp.
Wydane: (2015-02-01)

A Major Genetic Factor at Chromosome 9p Implicated in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration (FTLD)
od: Gijselinck, Ilse, i wsp.
Wydane: (2012)

Voxel-based morphometry in amyotrophic lateral sclerosis
od: I. S. Bakulin, i wsp.
Wydane: (2019-01-01)

Dynamics of Onset and Progression in Amyotrophic Lateral Sclerosis
od: Michael Swash, i wsp.
Wydane: (2025-06-01)

Clinical features of fatigue in amyotrophic lateral sclerosis
od: E. V. Pervushina, i wsp.
Wydane: (2025-04-01)

Presymptomatic genetic counseling in amyotrophic lateral sclerosis
od: Yu. A. Shpilyukova, i wsp.
Wydane: (2018-01-01)

The emerging role of cellular senescence in amyotrophic lateral sclerosis
od: Xingli Tan, i wsp.
Wydane: (2025-08-01)

Amyotrophic lateral sclerosis: Clinical heterogeneity and approaches to classification
od: I. S. Bakulin, i wsp.
Wydane: (2017-11-01)

MOLECULAR STRUCTURE OF AMYOTROPHIC LATERAL SCLEROSIS IN RUSSIAN POPULATION
od: N. Yu. Abramycheva, i wsp.
Wydane: (2017-01-01)

Muscle ultrasound imaging in the diagnosis of amyotrophic lateral sclerosis
od: Yu. N. Rushkevich, i wsp.
Wydane: (2015-02-01)

Quality of Life in Multiple Sclerosis Compared to Amyotrophic Lateral Sclerosis: Fatigue and Fast Disease Progression Interferes with the Ability to Psychosocially Adjust
od: Luisa T. Balz, i wsp.
Wydane: (2025-07-01)

Drug Delivery Options for Riluzole in the Treatment of Amyotrophic Lateral Sclerosis
od: Jaber Aghajani, i wsp.
Wydane: (2025-01-01)

Detection of bulbar amyotrophic lateral sclerosis based on speech analysis
od: A. D. Gvozdovich, i wsp.
Wydane: (2019-06-01)

2 cases transformation myasthenia gravis to amyotrophic lateral sclerosis
od: A. G. Sanadze, i wsp.
Wydane: (2015-02-01)

Immune checkpoint changes correlate with the progression and prognosis of amyotrophic lateral sclerosis
od: Sheng Chen, i wsp.
Wydane: (2025-12-01)

The role of some risk factors in the development and the flow of amyotrophic lateral sclerosis
od: A. V. Lebedev
Wydane: (2009-02-01)

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications
od: Farah Anjum, i wsp.
Wydane: (2025-06-01)

Pupil response as a window into cognitive processing in amyotrophic lateral sclerosis
od: Mohamad El Haj, i wsp.
Wydane: (2025-09-01)

Unlocking amyotrophic lateral sclerosis: the role of adiponectin in inflammation and disease progression
od: Mei Tian, i wsp.
Wydane: (2025-07-01)